| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Ambrx Biopharma Inc. (NYSE: AMAM)
AMAM Technical Analysis
5
| As on 9th Jun 2023 AMAM STOCK Price closed @ 14.70 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.55 & Strong Buy for SHORT-TERM with Stoploss of 6.26 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AMAMSTOCK Price
| Open | 14.40 | Change | Price | % |
| High | 14.99 | 1 Day | 0.29 | 2.01 |
| Low | 14.21 | 1 Week | 0.69 | 4.93 |
| Close | 14.70 | 1 Month | 4.97 | 51.08 |
| Volume | 305144 | 1 Year | 5.38 | 57.73 |
| 52 Week High 14.97 | 52 Week Low 0.41 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| AMAM Daily Charts |
AMAM Intraday Charts |
Whats New @ Bazaartrend |
AMAM Free Analysis |
|
|
AMAM Important Levels Intraday
| RESISTANCE | 16.20 |
| RESISTANCE | 15.72 |
| RESISTANCE | 15.42 |
| RESISTANCE | 15.13 |
| SUPPORT | 14.27 |
| SUPPORT | 13.98 |
| SUPPORT | 13.68 |
| SUPPORT | 13.20 |
AMAM Forecast May 2024
| 4th UP Forecast | 25.32 |
| 3rd UP Forecast | 21.91 |
| 2nd UP Forecast | 19.81 |
| 1st UP Forecast | 17.7 |
| 1st DOWN Forecast | 11.7 |
| 2nd DOWN Forecast | 9.59 |
| 3rd DOWN Forecast | 7.49 |
| 4th DOWN Forecast | 4.08 |
AMAM Weekly Forecast
| 4th UP Forecast | 19.07 |
| 3rd UP Forecast | 17.67 |
| 2nd UP Forecast | 16.80 |
| 1st UP Forecast | 15.94 |
| 1st DOWN Forecast | 13.46 |
| 2nd DOWN Forecast | 12.60 |
| 3rd DOWN Forecast | 11.73 |
| 4th DOWN Forecast | 10.33 |
AMAM Forecast2024
| 4th UP Forecast | 43.43 |
| 3rd UP Forecast | 34.22 |
| 2nd UP Forecast | 28.52 |
| 1st UP Forecast | 22.83 |
| 1st DOWN Forecast | 6.57 |
| 2nd DOWN Forecast | 0.88 |
| 3rd DOWN Forecast | -4.82 |
| 4th DOWN Forecast | -14.03 |
Ambrx Biopharma Inc. ( NYSE USA Symbol : AMAM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AMAM Business Profile
Ambrx Biopharma Inc., a clinical-stage biologics company, focuses on discovering and developing engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gastric/gastroesophageal junction cancer, and other solid tumors, including ongoing Phase 2/3 clinical trials for the treatment of HER2-positive metastatic breast cancer and gastric cancer. The company is also developing two earlier-stage product candidates, including ARX517, an anti-PSMA ADC, which is in a Phase 1 clinical trial for the treatment of prostate cancer and other solid tumors; and ARX305, an anti-CD70 ADC in investigational new drug-enabling studies for the treatment of renal cell carcinoma and other cancers, as well as other multiple product candidates targeting immuno-oncology applications. In addition, it is developing ARX102, an immuno-oncology IL-2 pathway agonist to stimulate the patient's own immune system by targeting the ß and gamma receptors on the cytotoxic T cell; and ARX822, a fab-small molecule bispecific that is in preclinical development for cancers. Ambrx Biopharma Inc. has collaborations with various pharmaceutical companies, which include Bristol Myers Squibb Company; AbbVie Inc.; Astellas Pharma Inc.; and Elanco Animal Health. The company was founded in 2003 and is based in La Jolla, California. Address: 10975 North Torrey Pines Road, La Jolla, CA, United States, 92037
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service